GLP-1

Supporting Your GLP-1 Population Now and Over Time

For organizations investing in GLP-1 therapies, providing access to medication is only the first step. Success depends largely on how well individuals navigate the day-to-day realities of treatment: Are they getting enough protein and fluids? How should they exercise when they feel tired or nauseous? How do they lose weight while preserving muscle? And over time, how do they build sustainable habits that support better health? To maximize the value of these medications, organizations need to provide both immediate support for daily challenges and also help them to build healthier habits for the long term. 

The Hard Part Happens After Treatment Begins

Starting GLP-1 therapy often begins with a clear plan, but the following weeks rarely go exactly as expected. Appetite can change, energy levels fluctuate, and gastrointestinal side effects can make it difficult to maintain healthy routines, including physical activity.

A 2025 JAMA study of more than 125,000 adults found that nearly 65% of GLP-1 users without type 2 diabetes discontinued treatment within a year, with gastrointestinal side effects cited as a primary factor. 

No single solution can address every barrier to treatment adherence. However, these findings make a strong case for providing more support as people adjust to GLP-1 therapy. And because their needs can change from one day to the next, that support needs to change too.  

From Static Advice to Adaptive Guidance

This is where agentic health AI can help. While a generic exercise plan may set fixed weekly targets, an adaptive system can use current data and context to determine what makes sense next.    

Many GLP-1 programs offer coaching, tracking, or both. Pear® goes further by connecting movement, nutrition, recovery, and real-world feedback through Training Intelligence®. Its GLP-1 companion combines targeted strength training and cardio with the ability to reduce intensity when more recovery is needed.  Simultaneously, it tracks protein intake and hydration in real time to help people stay fueled for activity.  The result is guidance that can change depending on the person and the circumstances. 

Muscle Preservation Should Be Non-Negotiable

Protecting lean body mass is essential during GLP-1 therapy. A 2026 meta-analysis of 20 randomized trials (15,000+ participants) found that lean mass accounted for roughly 25% to 39% of total weight lost on GLP-1s, threatening long-term strength, mobility, and metabolic health. 

Resistance training is a primary safeguard against muscle loss. The same 2026 analysis showed that interventions including resistance training produced the best results for muscle preservation. For organizations supporting GLP-1 users, strength training should be a key component of the overall treatment strategy.

Aligning with Broader Healthcare Shifts

Access to medication is only one part of GLP-1 therapy. Healthcare leaders and regulators increasingly recognize that medication without lifestyle support falls short. The Centers for Medicare & Medicaid Services’ (CMS) BALANCE Model reflects this shift by pairing GLP-1 coverage with structured interventions that promote healthier eating, physical activity, and long-term health.  

Pear Health Labs®: Supporting the GLP-1 Journey for the Short and Long-Term

GLP-1s are changing what’s possible in obesity treatment, but they don’t remove the need to build healthier habits. Pear’s GLP-1 support brings together three essential elements: resistance training to protect muscle, activity that adapts to fatigue or stress, and nutrition support. Rather than leaving people to manage each of these on their own, Pear provides personalized, day-to-day guidance that adjusts as needs change. That can help organizations address immediate treatment challenges while supporting the healthier habits that matter over time. 

More Blog Posts

Safer by Design: Balancing AI Personalization with Evidence-Based Limits

November 17, 2026

Millions of people are turning to generative AI for medical and fitness advice, opening new possibilities for more accessible, personalized health guidance. However, AI-generated recommendations aren't always accurate or safe. In exercise programming, inappropriate advice could lead to overexertion, inadequate recovery, or injury. As AI takes on a greater role in supporting physical activity, the…

Read More

Digital Health Technology: Why Exercise Recovery Matters

November 4, 2026

Many digital fitness programs track workouts, reward consistency, and encourage users to keep moving. However, when it comes to long-term health, more isn’t always better. Whether someone is starting an exercise program, rebuilding strength, or managing a chronic condition, factors such as poor sleep, fatigue, or dehydration can affect how much activity they can safely…

Read More
exercise

Exercise Snacking: The Science Behind Short Workouts and Better Engagement

October 26, 2026

Physical inactivity continues to be a persistent and costly challenge for health plans and organizations working to improve population health. Traditional exercise programs often require 30 minutes or more of continuous activity, creating a barrier for people who are inactive, deconditioned, or short on time. But improving health doesn’t necessarily require lengthy workout sessions. There…

Read More
glp-1

GLP-1s and Muscle Preservation: A New Measure of Treatment Value

October 26, 2026

For health plans, provider networks, and pharmaceutical leaders supporting GLP-1 therapy, clinical success is no longer just about the number of pounds lost. At a net cost of $7,000 to $10,000+ per member annually, the treatment's value increasingly depends on the quality of weight loss, specifically how much fat is lost, how much muscle is…

Read More

How HR Teams Are Restructuring GLP-1 Benefits

October 5, 2026

With employer healthcare costs projected to rise by 8% to 9% in 2027, many organizations are reevaluating high-cost benefits such as GLP-1 coverage. Demand for these medications remains strong, but because treatment may be long term, offering broad coverage can put significant pressure on pharmacy budgets. However, eliminating coverage can limit access to effective treatment…

Read More
Exercise guidance

From Numbers to Next Steps: Turning Data into Exercise Guidance

September 17, 2026

Health data is everywhere. Wearables monitor sleep, heart rate, and activity. Connected devices measure everything from weight to medication use. Yet, each day, all that information still has to help answer one practical question: What should I do today? For organizations aiming to improve outcomes across large populations, answering that question intelligently and repeatedly could…

Read More